/Investor DB

TransLink Capital — 2015 Investments

4 investments dated 2015 · listed companies and verified rows first · show all

Appceleratorappcelerator.comAug 2015 · $22M

Mountain View, US

Jeffrey Haynie(Executive Officer, Director)Nolan Wright(Director)MIKE ASHER(Executive Officer)

BoardNavin Chadda(Director)John Occhipinti(Director)inLarry Augustin(Director)in

Co-investorsRembrandt Venture PartnersEbayEDB InvestmentsMayfield FundPresidio VenturesRelay Ventures+4 more

Epicgetepic.com𝕏Oct 2015

Epic! is a digital library platform that provides access to books and reading materials for educational institutions and individual readers.

Digital HealthEdTechMinot, US

Kevin DonahueinSuren MarkosianLes Wright(Executive Officer)Todd Berning(Executive Officer)in

BoardJay Eum(Director)SaeMin Ahn(Director)

Co-investors500 GlobalMaven VenturesMenlo VenturesSocial StartsSpider CapitalStructural Capital+3 more

Guavusguavus.comJun 2015

The site at this domain is a consumer guide to online casinos in Florida, publishing reviews, rankings, and explanations of gambling laws, bonuses, payment methods, and responsible play.

Media & EntertainmentSan Mateo, US

Anukool Lakhina(Executive Officer, Director)

BoardJose Suarez(Director)Amit Shah(Director)inBrian Wilcove(Director)Andrew Fligel(Director)Michael LaJoie(Director)

Co-investorsQuestMark PartnersArtiman VenturesGoldman SachsIntel CapitalSingTel Innov8 Pte Ltd.Sofinnova Ventures

Hzohzo.comin𝕏Aug 2015

HZO provides turnkey protective thin-film coating services that shield electronic components and products from environmental hazards such as moisture and corrosion.

Advanced ManufacturingHardwareNew MaterialsDraper, US

Michael Bartholomeusz(Executive Officer, Director)inJay Suel(Executive Officer)Paul S Clayson(Executive Officer, Director)in

BoardDouglas Jamison(Director)Patrick Poon(Director)Kamal Bherwani(Director)

Co-investorsHorizons VenturesIron Gate Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.